Gastroenterology Clinical Trials in New York, NY

As of June 2026, 68 paid clinical trials are recruiting for Gastroenterology in New York, New York. Gastroenterology trials test new biologics for IBD, antifibrotic agents for NASH, motility drugs, and endoscopic interventions across Crohn's, ulcerative colitis, fatty liver disease, and functional GI disorders. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: June 12, 2026.

Filter results

Filter results

State

City

Facility

Phase

Study type

Intervention

Recruitment status

Condition

Sex

Age

Healthy volunteers only

68 clinical trials for Gastroenterology

·Clear filters·↓ Download CSV

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

for Crohn's Disease

Drug: Tulisokibart

87 locations incl. Dothan

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 16 - 80

Code: NCT06430801·Phase 3·Recruiting

Apply to this trial

Social Determinants of Health, Medication Use, and Quality of Life in Inflammatory Bowel Disease

for Inflammatory Bowel Diseases

2 locations incl. New York

Sponsor: Montefiore Medical Center

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT06266663·Recruiting

Apply to this trial

Human Models of Selective Insulin Resistance: Alpelisib, Part I

for Insulin Resistance

1 location in New York

Sponsor: Columbia University

Sex: All·Age: 18 - 70·Accepts healthy volunteers

Code: NCT06354088·Phase 1·Recruiting

Apply to this trial

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

for Crohn's Disease

Drug: Ustekinumab

45 locations incl. Dothan

Sponsor: Takeda

Sex: All·Age: 18 - 70

Code: NCT06045754·Phase 4·Recruiting

Apply to this trial

A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease

for Crohn's Disease

15 locations incl. Los Angeles

Sponsor: Eli Lilly and Company

Sex: All·Age: 2 - 17

Code: NCT05509777·Phase 3·Recruiting

Apply to this trial

A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

for Crohn's Disease

Drug: Guselkumab

14 locations incl. Los Angeles

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 2 - 17

Code: NCT05923073·Phase 3·Recruiting

Apply to this trial

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

for Crohn's Disease

29 locations incl. Los Angeles

Sponsor: Takeda

Sex: All·Age: 18 - 75

Code: NCT06233461·Phase 2·Recruiting

Apply to this trial

An Observational Study of Patients With Chronic Liver Disease

for Chronic Liver Disease

10 locations incl. Los Angeles

Sponsor: Target PharmaSolutions, Inc.

Sex: All·Age: 18+

Code: NCT05744713·Enrolling By Invitation

Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)

for Ulcerative Colitis

13 locations incl. Birmingham

Sponsor: Northwestern University

Sex: All·Age: 18 - 85

Code: NCT05987852·Recruiting

Apply to this trial

A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease

for Crohn's Disease

Drug: Risankizumab

11 locations incl. Phoenix

Sponsor: AbbVie

Sex: All·Age: 2 - 17

Code: NCT05995353·Phase 3·Recruiting

Apply to this trial

Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States

for Cirrhosis

13 locations incl. La Jolla

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Sex: All·Age: 18 - 75

Code: NCT05832229·Phase 2·Recruiting

Apply to this trial

Predictive Biomarker for Endoscopic Therapy in Chronic Pancreatitis

for Chronic Pancreatitis

1 location in New York

Sponsor: NYU Langone Health

Sex: All·Age: 18+

Code: NCT06267365·Recruiting

Apply to this trial

Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

for Carcinoma, Hepatocellular

32 locations incl. Birmingham

Sponsor: VA Office of Research and Development

Sex: All·Age: 18 - 75

Code: NCT05486572·Recruiting

Apply to this trial

Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease

for Crohn Disease

22 locations incl. Phoenix

Sponsor: Connecticut Children's Medical Center

Sex: All·Age: 6 - 17

Code: NCT05781152·Phase 4·Recruiting

Apply to this trial

Biomarkers of Airway Disease, Barrett's and Underdiagnosed Reflux Noninvasively (BADBURN)

for Airway Disease

1 location in New York

Sponsor: NYU Langone Health

Sex: Male·Age: 37 - 90

Code: NCT05216133·Enrolling By Invitation

Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia

for Barretts Esophagus With Dysplasia

23 locations incl. Los Angeles

Sponsor: University of Colorado, Denver

Sex: All·Age: 18 - 89

Code: NCT05753748·Recruiting

Apply to this trial

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

for Ulcerative Colitis

22 locations incl. Irvine

Sponsor: University of California, San Diego

Sex: All·Age: 18+

Code: NCT05230173·Recruiting

Apply to this trial

Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance

for Barrett Esophagus

14 locations incl. Gilbert

Sponsor: University of Colorado, Denver

Sex: All·Age: 18 - 89

Code: NCT05530343·Recruiting

Apply to this trial

Diet and Meal Timing in Patients With Metabolic Dysfunction Associated Steatoic Liver Disease

for Non-Alcoholic Fatty Liver Disease

1 location in New York

Sponsor: Weill Medical College of Cornell University

Sex: All·Age: 18 - 65·Accepts healthy volunteers

Code: NCT05332613·Recruiting

Apply to this trial

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

for Ulcerative Colitis

11 locations incl. San Francisco

Sponsor: Eli Lilly and Company

Sex: All·Age: 2 - 19

Code: NCT04844606·Phase 3·Recruiting

Apply to this trial

Longitudinal Oral Microbiome Sampling for BE

for Barrett Esophagus

2 locations incl. Ann Arbor

Sponsor: Columbia University

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT05133102·Recruiting

Apply to this trial

Low Dose IL-2 for the Treatment of Crohn's Disease

for Crohn Disease

3 locations incl. Boston

Sponsor: Boston Children's Hospital

Sex: All·Age: 12 - 80

Code: NCT04263831·Phase 1, Phase 2·Recruiting

Apply to this trial

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

for Autoimmune Disease

Drug: Nivolumab

51 locations incl. Birmingham

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT03816345·Phase 1·Recruiting

Apply to this trial

The Johns Hopkins Heartburn Center Registry

for Gastroesophageal Reflux Disease

9 locations incl. Orange

Sponsor: Johns Hopkins University

Sex: All·Age: 18+

Code: NCT03853772·Enrolling By Invitation

Autologous Stem Cell Transplant for Crohn's Disease

for Crohn Disease

1 location in New York

Sponsor: Aaron Etra

Sex: All·Age: 18+

Code: NCT03219359·Phase 2·Recruiting

Apply to this trial

Improving the Quality of Care for Adults With Inflammatory Bowel Disease

for Crohn's Disease

29 locations incl. Los Angeles

Sponsor: Dartmouth-Hitchcock Medical Center

Sex: All·Age: 18 - 99

Code: NCT02791854·Enrolling By Invitation

Study of the Kono-S Anastomosis Versus the Side-to-side Functional End Anastomosis

for Crohn's Disease

6 locations incl. Boston

Sponsor: Weill Medical College of Cornell University

Sex: All·Age: 18 - 90

Code: NCT03256240·Recruiting

Apply to this trial

Pancreas Registry and High Risk Registry

for Pancreas Cancer

2 locations incl. New York

Sponsor: Icahn School of Medicine at Mount Sinai

Sex: All·Age: 18+

Code: NCT02775461·Recruiting

Apply to this trial

Conditions in Gastroenterology (New York, NY)

Crohn's disease· 32 Ulcerative colitis· 18 Inflammatory bowel disease (IBD)· 9 Cirrhosis / liver disease· 7 Non-alcoholic fatty liver disease (NAFLD)· 6 Barrett's esophagus· 5 Chronic pancreatitis· 2 Celiac disease· 2